BusinessLogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy 25th Anniversary Congress in BerlinBy Nasdaq OMXOct 16, 2017, 1:01 PM UTC
BusinessLogicBio Therapeutics Announces $50 Million in Financing to Develop Novel Gene Medicines for Pediatric PatientsBy Nasdaq OMXJun 28, 2017, 6:03 AM UTC
BusinessIntellia Therapeutics Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing Technology PatentBy Nasdaq OMXApr 11, 2017, 11:30 AM UTC
